טוען...
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Schizophrenia (SCZ) is a severe mental disorder with high morbidity and lifetime disability rates. Patients with SCZ have a higher risk of developing metabolic comorbidities such as obesity and diabetes mellitus, leading to increased mortality. Antipsychotics (APs), which are the mainstay in the tre...
שמור ב:
Main Authors: | , , , , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
SAGE Publishing
2022-05-01
|
סדרה: | Therapeutic Advances in Psychopharmacology |
גישה מקוונת: | https://doi.org/10.1177/20451253221096525 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|